newsfilter
← Latest News
GlobeNewswire·

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues

NTHI
  • NeOnc Technologies Holdings (NASDAQ: NTHI) CEO Amir Heshmatpour purchased 70,000 shares for approximately $230,510.
  • The transactions occurred on November 5 & 6, involving 30,000 shares at ~$3.17 & 40,000 shares at ~$3.39.
  • Heshmatpour's total beneficial ownership rose to ~7.77 million shares, including affiliated entities.
  • This purchase continues a 2026 buying pattern that previously saw insiders acquire 160,016 shares for ~$629,000 following positive Phase 2a NEO100 results.
  • NeOnc is developing NEO100 for recurrent IDH1-mutant high-grade glioma & NEO212 for central nervous system cancers.
  • The Phase 2a NEO100 study met its primary endpoint with 48.9% six-month progression-free survival against a 20% benchmark.
  • Updated NEO100 data & NEO212 Phase 1 findings are scheduled for presentation at the Society for Neuro-Oncology annual meeting on November 13.